Atreca Inc Analysis
| BCELDelisted Stock | USD 1.04 0.02 1.89% |
Atreca Inc is overvalued with Real Value of 0.89 and Hype Value of 1.04. The main objective of Atreca pink sheet analysis is to determine its intrinsic value, which is an estimate of what Atreca Inc is worth, separate from its market price. There are two main types of Atreca's stock analysis: fundamental analysis and technical analysis.
The Atreca pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Atreca |
Atreca Pink Sheet Analysis Notes
About 25.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.28. Some equities with similar Price to Book (P/B) outperform the market in the long run. Atreca Inc recorded a loss per share of 2.5. The entity had not issued any dividends in recent years. The firm had 1:6 split on the 7th of June 2019. Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Atreca, Inc. was incorporated in 2010 and is based in San Carlos, California. Atreca Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 105 people.The quote for Atreca Inc is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Atreca Inc please contact John MBA at 650 595 2595 or go to https://www.atreca.com.Atreca Inc Investment Alerts
| Atreca Inc is not yet fully synchronised with the market data | |
| Atreca Inc has some characteristics of a very speculative penny stock | |
| Atreca Inc has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (97.76 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Atreca Inc currently holds about 101.73 M in cash with (65.08 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.64, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Atreca Inc Upcoming and Recent Events
| 3rd of April 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 3rd of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Atreca Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.02 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Atreca's market, we take the total number of its shares issued and multiply it by Atreca's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Atreca Inc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Atreca insiders, such as employees or executives, is commonly permitted as long as it does not rely on Atreca's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Atreca insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Tito Serafini over a year ago Sale by Tito Serafini of 5487 shares of Atreca | ||
Robinson William Hewitt over a year ago Acquisition by Robinson William Hewitt of 12000 shares of Atreca subject to Rule 16b-3 | ||
Tito Serafini over a year ago Acquisition by Tito Serafini of 43750 shares of Atreca subject to Rule 16b-3 |
Atreca Outstanding Bonds
Atreca issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Atreca Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Atreca bonds can be classified according to their maturity, which is the date when Atreca Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View |
Atreca Predictive Daily Indicators
Atreca intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Atreca pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Atreca Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Atreca prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Atreca shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Atreca. By using and applying Atreca Pink Sheet analysis, traders can create a robust methodology for identifying Atreca entry and exit points for their positions.
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Atreca, Inc. was incorporated in 2010 and is based in San Carlos, California. Atreca Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 105 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Atreca to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Atreca Pink Sheet
If you are still planning to invest in Atreca Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Atreca's history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |